PRELUDE CAPITAL MANAGEMENT, LLC
Position in PBYI — Puma Biotechnology, Inc.
CIK 1387508
NEW YORK, NY
Position in PBYI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$117,882
-$73,398 QoQ
Shares Held
18,448
-42.6% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $45,146,517 across 96 Biotechnology names. PBYI ranks #53 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PGEN |
Precigen, Inc.
|
1,270,053 | $4,915,105 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
111,593 | $3,091,126 | |
| 3 | PRAX |
Praxis Precision Medicines, Inc.
|
9,064 | $2,920,330 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
64,222 | $2,471,904 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
29,658 | $2,227,019 | |
| 6 | ELVN |
Enliven Therapeutics, Inc.
|
52,578 | $2,061,057 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
17,073 | $1,660,349 | |
| 8 | ALMS |
Alumis Inc.
|
74,758 | $1,646,918 |
All Filings in PBYI
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $117,882 | 18,448 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $191,280 | 32,148 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $204,020 | 38,422 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $114,637 | 33,422 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $111,592 | 37,700 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $75,640 | 24,800 | Shares | Other | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||